fattyacid composit serumlecithin cysticfibrosi patient without steatorrhoea letter investig fattyacid composit serumlecithin four group cf patient defin pancreat function evalu 72h quantit stool fat determin coeffici fat absorpt cf patient without pancreat insuffici pancreat extract significantli higher percentag linol acid patient ani group alter fattyacid composit serumlipid fraction seem secondari consequ pancreat insuffici commonli associ cf diseas direct metabol defect suggest